News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Broadfoot Jill Marie
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/21/2023 |
4
| Broadfoot Jill Marie (CFO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 84,023 options to buy
@ $2.195, valued at
$184.4k
|
|
| 02/06/2023 |
4
| Broadfoot Jill Marie (CFO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Sold 1,566 shares
@ $2.36, valued at
$3.7k
Exercised 3,750 restricted stock units
@ $0 |
|
| 07/15/2022 |
4
| Broadfoot Jill Marie (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 15,500 shares
@ $0
Granted 31,000 options to buy
@ $0.2309, valued at
$7.2k
|
|
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2022 |
4
| Broadfoot Jill Marie (CFO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Bought 1,923 shares
@ $6.75, valued at
$13k
|
|
| 11/23/2021 |
4
| Broadfoot Jill Marie (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC|
Txns:
| Granted 15,000 shares
@ $0
Granted 30,000 options to buy
@ $0.72, valued at
$21.6k
|
|
| 08/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Broadfoot Jill Marie (CFO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Sold 390 shares
@ $7.66, valued at
$3k
Exercised 892 restricted stock units
@ $0 |
|
| 02/08/2021 |
4
| Broadfoot Jill Marie (CFO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 50,000 options to buy
@ $4.52, valued at
$226k
|
|
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2020 |
4
| Broadfoot Jill Marie (CFO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 30,000 options to buy
@ $4.06, valued at
$121.8k
|
|
| 02/07/2020 |
4
| Broadfoot Jill Marie (CFO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Sold 375 shares
@ $4.03, valued at
$1.5k
Granted 23,359 options to buy
@ $4.39, valued at
$102.5k
Exercised 893 restricted stock units
@ $0 |
|
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2018 |
4
| Broadfoot Jill Marie (CFO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Bought 26,000 shares
@ $0.8122, valued at
$21.1k
Bought 38,000 shares
@ $0.8352, valued at
$31.7k
|
|
| 09/18/2018 |
4
| Broadfoot Jill Marie (CFO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Bought 26,000 shares
@ $0.7329, valued at
$19.1k
|
|
| 08/01/2018 |
4
| Broadfoot Jill Marie (CFO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 200,000 options to buy
@ $0.8151, valued at
$163k
|
|
| 04/03/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/15/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/11/2011 |
4
| Broadfoot Jill Marie (Sr Vice President, CFO, Sec) has filed a Form 4 on VICAL INC|
Txns:
| Bought 60,000 shares
@ $0.01, valued at
$600
Granted 42,777 options to buy
@ $2.14, valued at
$91.5k
Granted 137,223 options to buy
@ $2.14, valued at
$293.7k
|
|
| 01/12/2010 |
4
| Broadfoot Jill Marie (Sr Vice President, CFO, Sec) has filed a Form 4 on VICAL INC|
Txns:
| Bought 50,000 shares
@ $0.01, valued at
$500
Granted 48,740 options to buy
@ $3.47, valued at
$169.1k
Granted 101,260 options to buy
@ $3.47, valued at
$351.4k
|
|
| 01/12/2009 |
4
| Church Jill Marie (Vice President, CFO, Secretary) has filed a Form 4 on VICAL INC |
|
|